PHARMACOKINETICS OF SUPEROXIDE DISMUTASE IN RATS AFTER ORAL ADMINISTRATION
Corinne Regnault, Mireille Soursac, Monique Roch-Arveiller, E. Postaire, Georges F. Hazebroucq
Abstract
Corinne Regnault, Mireille Soursac, Monique Roch-Arveiller, E. Postaire, Georges F. Hazebroucq
Abstract
The kinetic behaviour of bovine erythrocyte Cu--Zn SOD was investigated in Sprague Dawley male rats after subcutaneous and oral administrations of doses ranging from 0·5 to 20 mg kg−1. Studies have been carried out with SOD and SOD encapsulated into liposomes containing or not containing ceramides. The maximum concentration (Cmax) in blood cell pellets ranged from 8·65 to 11·03 U/mg haemoglobin (Hb) after subcutaneous injection, and from 4·48 to 8·23 U/mg Hb after oral administration. The maximum concentrations were reached in 5 h (t max) for the two routes. Comparison between the areas under the curves (AUCs) obtained after subcutaneous and oral administration allowed the calculation of relative bioavailability (F ′). The maximum bioavailability after oral administration was 14% for free SOD, 22% for SOD encapsulated into liposomes, and 57% when ceramides were added to liposomes. Poor SOD bioavailability was enhanced by liposome encapsulation, and ceramide addition seemed to be beneficial for oral encapsulated SOD administration.
OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The kinetic behaviour of bovine erythrocyte Cu--Zn SOD was investigated in Sprague Dawley male rats after subcutaneous and oral administrations of doses ranging from 0·5 to 20 mg kg−1. Studies have been carried out with SOD and SOD encapsulated into liposomes containing or not containing ceramides. The maximum concentration (Cmax) in blood cell pellets ranged from 8·65 to 11·03 U/mg haemoglobin (Hb) after subcutaneous injection, and from 4·48 to 8·23 U/mg Hb after oral administration. The maximum concentrations were reached in 5 h (t max) for the two routes. Comparison between the areas under the curves (AUCs) obtained after subcutaneous and oral administration allowed the calculation of relative bioavailability (F ′). The maximum bioavailability after oral administration was 14% for free SOD, 22% for SOD encapsulated into liposomes, and 57% when ceramides were added to liposomes. Poor SOD bioavailability was enhanced by liposome encapsulation, and ceramide addition seemed to be beneficial for oral encapsulated SOD administration.
Key concepts: Bioavailability, Oral administration, Pharmacokinetics, Pharmacology, Liposome, Cmax, Chemistry, Superoxide dismutase